From Alphastreet - Earnings Decoded. Market Intelligence Delivered · AlphaStreet Newsdesk · · 40s
PTC Therapeutics Rises 5.5% in Biotech Rally
Biotech stocks surge as sector-wide momentum lifts PTC Therapeutics 5.5%.
In brief
Biotech stocks surge as sector-wide momentum lifts PTC Therapeutics 5.5%. PTC Therapeutics gained 5.5% Monday due to broader biotech sector strength. Originally reported by Alphastreet - Earnings Decoded. Market Intelligence Delivered.
Sector Momentum
PTC Therapeutics rose 5.5% Monday as biotech stocks rallied across the board.
Stock Details
The stock closed at $66.13 on volume of 1.0 million shares.
Peer Performance
GRAL climbed 4.1% and TVTX added 3.2% on the same session.
No News Catalyst
This rally followed sector-wide momentum, not company-specific news.
Analyst Sentiment
Recent analyst sentiment shows one target raise and zero cuts in seven days.
In short
PTC Therapeutics gained 5.5% Monday due to broader biotech sector strength.
